FDA backs development of radiation-sickness countermeasures

08/13/2013 | GenomeWeb Daily News (free registration)

The Wyss Institute at Harvard University will use its organs-on-chips technology to evaluate medical countermeasures against acute radiation syndrome, or ARS, under a $5.6 million grant from the FDA. As part of the contract, scientists at Wyss will test possible countermeasures for ARS on models of radiation damage in bone marrow, gut and lung organs-on-chips.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY